Suppr超能文献

CT识别高危结肠癌的诊断准确性:一项系统评价和荟萃分析。

Diagnostic accuracy of CT for identifying high-risk colon cancer: a systematic review and meta-analysis.

作者信息

Shkurti Jona, van den Berg Kim, Tissier Renaud L M, van der Mierden Stevie, Lahaye Max J, Beets-Tan Regina G H, Nederend Joost

机构信息

Department of Diagnostic Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

GROW School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.

出版信息

Eur Radiol. 2025 Aug 16. doi: 10.1007/s00330-025-11844-2.

Abstract

OBJECTIVES

This systematic review and meta-analysis aimed to assess the diagnostic accuracy of CT in differentiating high-risk from low-risk colon cancer, with a focus on staging parameters and the impact of CT slice thickness.

MATERIALS AND METHODS

A systematic search of Ovid MEDLINE and Embase.com was conducted from January 1, 2015, to September 24, 2024, to identify studies evaluating CT-based staging accuracy using histopathology as the reference standard. The QUADAS-2 tool assessed the risk of bias. Pooled sensitivity, specificity, and diagnostic odds ratio (DOR) were calculated using a bivariate random-effects model. Subgroup analyses explored the influence of CT techniques, slice thickness, and study design on diagnostic performance.

RESULTS

The meta-analysis included forty-four studies. CT demonstrated 83% sensitivity (95% CI, 79-86%) and 70% specificity (95% CI, 66-74%) for detecting pT3-T4 tumors (DOR: 10.0). For pT3cd-T4 (> 5 mm muscularis propria invasion), sensitivity was 67% (61-73%), specificity 88% (83-92%) and DOR 13.7 (9.0-21.0). Detection of pN+ yielded 64% sensitivity (60-68%), 67% specificity (62-72%) and DOR of 3.5 (3.0-4.2). Sensitivity for extramural venous invasion (EMVI+) was 49% (41-56%), with 77% specificity (67-84%) and DOR 3.0 (2.0-4.4). Studies with < 5 mm slice thickness showed higher sensitivity but lower specificity. High I² values indicated substantial heterogeneity across studies.

CONCLUSION

CT demonstrates high sensitivity for detecting T3-T4 colon cancer but moderate sensitivity for nodal involvement and EMVI+. Diagnostic performance varies with technical factors, emphasizing the need for standardized imaging protocols and supplementary diagnostic tools to improve colon cancer staging.

REGISTRATION

PROSPERO (International Prospective Register of Systematic Reviews) CRD42022374615.

KEY POINTS

Question Accurate CT staging is crucial for guiding neoadjuvant therapy in colon cancer, but its ability to distinguish high-risk from low-risk cases remains uncertain. Findings CT showed high sensitivity for distinguishing pT3-T4 tumors but only moderate sensitivity for pT3cd-T4, nodal involvement, and extramural venous invasion. Clinical relevance This systematic review critically evaluates CT diagnostic accuracy in colon cancer staging, revealing its strengths and limitations. The findings highlight the need for optimized imaging protocols and complementary tools to enhance risk stratification and guide clinical decisions.

摘要

目的

本系统评价和荟萃分析旨在评估CT在鉴别高危和低危结肠癌方面的诊断准确性,重点关注分期参数以及CT层厚的影响。

材料与方法

于2015年1月1日至2024年9月24日对Ovid MEDLINE和Embase.com进行系统检索,以识别使用组织病理学作为参考标准评估基于CT的分期准确性的研究。采用QUADAS-2工具评估偏倚风险。使用双变量随机效应模型计算合并敏感性、特异性和诊断比值比(DOR)。亚组分析探讨了CT技术、层厚和研究设计对诊断性能的影响。

结果

荟萃分析纳入了44项研究。CT检测pT3-T4肿瘤的敏感性为83%(95%CI,79-86%),特异性为70%(95%CI,66-74%)(DOR:10.0)。对于pT3cd-T4(肌层固有层浸润>5mm),敏感性为67%(61-73%),特异性为88%(83-92%),DOR为13.7(9.0-21.0)。检测到pN+的敏感性为64%(60-68%),特异性为67%(62-72%),DOR为3.5(3.0-4.2)。壁外静脉侵犯(EMVI+)的敏感性为49%(41-56%),特异性为77%(67-84%),DOR为3.(2.0-4.4)。层厚<5mm的研究显示出较高的敏感性但较低的特异性。高I²值表明各研究间存在显著异质性。

结论

CT检测T3-T4期结肠癌具有较高的敏感性,但检测淋巴结受累和EMVI+的敏感性中等。诊断性能因技术因素而异,强调需要标准化的成像方案和辅助诊断工具以改善结肠癌分期。

注册信息

PROSPERO(国际系统评价前瞻性注册库)CRD42022374615。

要点

问题准确的CT分期对于指导结肠癌的新辅助治疗至关重要,但其区分高危和低危病例的能力仍不确定。研究结果CT在区分pT3-T4肿瘤方面显示出较高的敏感性,但对pT3cd-T4肿瘤、淋巴结受累和壁外静脉侵犯仅具有中等敏感性。临床意义本系统评价批判性地评估了CT在结肠癌分期中的诊断准确性,揭示其优势和局限性。研究结果强调需要优化成像方案和补充工具以加强风险分层并指导临床决策。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验